Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.

Item
http://www.wikidata.org/entity/Q33497983
Current stage in inflammatory bowel disease: What is next?Have we overestimated the benefit of human(ized) antibodies?Current and emerging drugs for the treatment of inflammatory bowel disease.Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.T-cell-directed therapies in inflammatory bowel diseases.IBD in 2010: optimizing treatment and minimizing adverse events.Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.Pathway-based approaches to the treatment of inflammatory bowel disease.Emerging treatments for ulcerative colitis: a systematic review.Emerging drugs to treat Crohn's disease.Administration of anti-CD3 antibodies modulates the immune response to an infusion of α-glucosidase in miceFecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH
P2860

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.

Item
http://www.wikidata.org/entity/Q33497983
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prospective randomized open-la ...... refractory ulcerative colitis.
@ast
Prospective randomized open-la ...... refractory ulcerative colitis.
@en
type
label
Prospective randomized open-la ...... refractory ulcerative colitis.
@ast
Prospective randomized open-la ...... refractory ulcerative colitis.
@en
prefLabel
Prospective randomized open-la ...... refractory ulcerative colitis.
@ast
Prospective randomized open-la ...... refractory ulcerative colitis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Prospective randomized open-la ...... refractory ulcerative colitis.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921